Ignite Creation Date:
2024-05-05 @ 5:36 PM
Last Modification Date:
2024-10-26 @ 9:33 AM
Study NCT ID:
NCT00483301
Status:
COMPLETED
Last Update Posted:
2012-05-03
First Post:
2007-05-30
Brief Title:
A Phase II Trial OF Carboplatin ABI-007 Abraxane And Sorafenib BAY 43-9006 in Metastatic Melanoma
Sponsor:
Mt Sinai Medical Center Miami
Organization:
Mt Sinai Medical Center Miami
Organization Data
Organization:
Mt Sinai Medical Center Miami
Class:
OTHER
Study ID:
MEL0205
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Mt Sinai Medical Center Miami
Lead Sponsor Class:
OTHER
Responsible Party:
Jose Lutzky
Responsible Party Title:
Study Principal Investigator
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Mt Sinai Medical Center Miami
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Bayer | INDUSTRY |
| Celgene Corporation | INDUSTRY |